Skip to content

Clinical trials

Stomach Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Not applicable Clear all

569 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20044
20063
20073
20088
20095
20107
201114
201217
201315
201422
201534
201632
201727
201828
201937
202043
202141
202245
202343
202449
202541
202646

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed199
Unknown status164
Recruiting110
Not yet recruiting49
Active, not recruiting18
Terminated15
Withdrawn10
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University26
Fujian Medical University15
RenJi Hospital12
Gangnam Severance Hospital11
The Affiliated Hospital of Qingdao University11
National Cancer Center, Korea9
Seoul National University Hospital9
Shandong University7
Tianjin Medical University Cancer Institute and Hospital7
Ajou University School of Medicine6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms569
Esophageal Neoplasms98
Pancreatic Neoplasms64
Colonic Neoplasms45
Colorectal Neoplasms37
Liver Neoplasms33
Lung Neoplasms31
Breast Neoplasms29
Neoplasms25
Rectal Neoplasms25

Trials

Showing 26 to 50 of 569. Each trial links to its page on Pharma Observatory.

469 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.